Osimertinib Combined With Intracranial SRT for EGFR-Mutant NSCLC With Symptomatic Brain Metastases

Clinical trial NCT07491211 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07491211
Sponsor: Fudan University
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

NSCLC (Advanced Non-small Cell Lung Cancer)Brain Metastases From Non-small Cell Lung Cancer (NSCLC)Osimertinib Stereotactic Radiation

Start date: 2019-07-19
Primary completion: 2025-03-31
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.